Tango Therapeutics TNGX Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's other noncash income (expense)?
- Tango Therapeutics (TNGX) reported other noncash income (expense) of -$21K in Q1 2026.
- How has Tango Therapeutics's other noncash income (expense) changed year-over-year?
- Tango Therapeutics's other noncash income (expense) decreased by 137.5% year-over-year, from $56K to -$21K.
- What is the long-term trend for Tango Therapeutics's other noncash income (expense)?
- Over 2 years (2021 to 2025), Tango Therapeutics's other noncash income (expense) has grown at a -44.9% compound annual growth rate (CAGR), from -$254K to $77K.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.